TRAVIS FORNEY: Open Payments
NPI 1285039297 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 28 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $108 |
| JAZZ PHARMACEUTICALS INC. | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $80 |
| Genentech USA, Inc. | 3 | $79 |
| ABBVIE INC. | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| TerSera Therapeutics LLC | 1 | $28 |
| Incyte Corporation | 1 | $26 |
| CSL Behring | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $21 |
Products named: LYNPARZA, ELAHERE, ZEPZELCA, RYBREVANT, TECVAYLI, HYQVIA, RYLAZE, DARZALEX.
Industry payments across TX — which companies pay providers there.
